Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. GeneDx Holdings Corp shares valued at $878,181 were sold by Stueland Katherine on Jul 01 ’25. At $90.94 per share, Stueland Katherine sold 9,657 shares. The insider’s holdings dropped to 4,940 shares worth approximately $0.45 million following the completion of this transaction.
Also, Feeley Kevin sold 1,344 shares, netting a total of over 122,471 in proceeds. Following the sale of shares at $91.12 each, the insider now holds 7,425 shares.
Before that, Kevin Feeley had added 5,805 shares to its account. In a trade valued at $535,900, the Officer bought GeneDx Holdings Corp shares for $92.32 each.
As published in their initiating research note from Guggenheim on May 15, 2025, GeneDx Holdings Corp [WGS] has been a Buy and the price target has been revised to $88. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early May. As of August 28, 2024, Wells Fargo has initiated its “an Equal weight” rating for WGS. Earlier on July 10, 2024, Craig Hallum initiated its rating. Their recommendation was “a Buy” for WGS stock.
Analyzing WGS Stock Performance
On last trading session, GeneDx Holdings Corp [NASDAQ: WGS] rose 2.03% to $91.61. The stock’s lowest price that day was $88.785, but it reached a high of $92.785 in the same session. During the last five days, there has been a surge of approximately 2.25%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 219.31%. Shares of the company reached a 52-week high of $117.75 on 04/29/25 and a 52-week low of $55.17 on 05/08/25.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 89.33, which, if violated, would cause prices to drop to 87.06. In the upper region, resistance lies at 93.33. The next price resistance is at 95.06. RSI (Relative Strength Index) is 66.50 on the 14-day chart, showing neutral technical sentiment.
Is GeneDx Holdings Corp subject to short interest?
Stocks of GeneDx Holdings Corp saw a sharp rise in short interest on 2025-06-13 jumping by 0.27 million shares to 3.75 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.47 million shares. A jump of 7.3% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.35.
Which companies own the most shares of GeneDx Holdings Corp (WGS)?
In terms of GeneDx Holdings Corp share price expectations, FactSet research, analysts set an average price target of 39.5 in the next 12 months, down nearly -56.01% from the previous closing price of $89.79. Analysts anticipate GeneDx Holdings Corp stock to reach 70 by 2025, with the lowest price target being 21. In spite of this, 3 analysts ranked GeneDx Holdings Corp stock as Buy at the end of 2025. On June 03, 2024, Jefferies assigned a price target of “a Hold” to the stock and resumed coverage with a $21.
